Liver Disease Clinical Trials

Concerned about high blood cholesterol and fatty liver disease? Wake Research Associates is enrolling volunteers in a study of the safety and effectiveness of an investigational drug for hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD).

A study testing the safety, tolerability, and effectiveness of a medication for individuals with non-alcoholic steatohepatitis (NASH). REF: x18-CLN

Data collection on patients with NAFLD/NASH to determine the natural course of the liver disease and to determine if certain lifestyle changes or diet changes that may be recommended by your doctor can affect NAFLD/NASH. Optional blood samples may be collected once a year to identify and understand the genetic ...

Data collection study to determine if certain lifestyle changes or changes in diet or other treatments that may be recommended by your doctors can affect PBC. Researchers are interested in observing how these lifestyle changes, counseling, or other treatments work in patients who are treated by their doctors in routine ...

Children who have Fatty Liver Disease are asked to participate in a research study being conducted by Montefiore Medical Center.

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for patients with non-alcoholic fatty liver disease accompanied by high cholesterol. Qualified participants receive study-related medical care from a board-certified physician, study medications, exams and evaluations.

People who have Fatty Liver Disease are asked to participate in a research study being conducted by North Shore University Hospital

People who have Nonalcoholic Steatohepatitis (NASH) and cirrhosis (F4 fibrosis) are asked to participate in a research study being conducted by North Shore University Hospital

People who have Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) are asked to participate in a research study being conducted by Montefiore Medical Center

The purpose of this study is to find out how safe and effective OCA may be in delaying or preventing specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. The investigational drug, OCA, is a modified (man-made) version of a ...